PPT-Module 3: Anemia in Chronic Kidney Disease
Author : julia | Published Date : 2022-02-14
Andrew Narva MD FASN amp Amy Barton Pai PharmD MHI FASN FCCP FNKF Andrew Narva MD FASN No financial disclosuresconflicts of interest Amy Barton Pai PharmD
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Module 3: Anemia in Chronic Kidney Dise..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Module 3: Anemia in Chronic Kidney Disease: Transcript
Andrew Narva MD FASN amp Amy Barton Pai PharmD MHI FASN FCCP FNKF Andrew Narva MD FASN No financial disclosuresconflicts of interest Amy Barton Pai PharmD MHI FASN FCCP FNKF. CKD. Dialysis. Renal Transplant. Bones can break, muscles can atrophy, glands can loaf, even the brain can go to sleep without immediate danger to survival. But -- should kidneys fail.... neither bone, muscle, nor brain could carry on.. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Chronic Kidney Disease: Detection and Management in Primary Care Julia Scialla, MD, MHS, FASN Associate Professor of Medicine and Public Health Sciences University of Virginia Adjunct Associate Professor of Medicine red blood cell mass . or . blood hemoglobin concentration. . In practice, anemia most commonly is defined by reductions in one or both of the following:. Hematocrit (HCT) – The HCT is the fractional volume of a whole blood sample occupied by RBCs, expressed as a percentage. As an example, the normal HCT in a child age 6 to 12 years is approximately 40 percent.. By Dr. Zahoor. 1. Anemia. What is Anemia?. . Anemia is present when there is decrease in hemoglobin (Hb) in the blood below the reference level for the age and sex . 2. 3. Normal Values for Peripheral Blood. referance. range for the age and sex. The normal ranges vary with age . -neonate < 14g/dl. -1-12mths < 10mg/dl. -1-12y< 11 g/dl. Causes of anemia can be from. Reduced cell production. Increased destruction. a pathophysiological condition in which the body cannot meet its demands for oxygen. . M: . Hb. <13.5 . Hct. <41 . F. : . Hb. <12 . Hct. <36 . Erythrocyte Indices . Hgb. M: 14.0-18.0 . Shekhar. Sharma. Assistant Professor,. Department . of . Nephrology. AIIMS, . Rishikesh. . Staging. Chronic kidney disease (CKD) encompasses a spectrum of different pathophysiologic processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR), present for >3 months.. Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . In CKD and HD patients dysfunction of . immu. ne . sy. stem . a. lterations. . belonge. to . . involv. ing. . i. nnate. and . a. daptive. . i. mmunity. in T and B lymphocytes (. Reduced . T regulatory cells and memory cells and increased innate cells). . Stuart M. c. Adam, MD, FRCPC. General Internal Medicine. The Moncton Hospital. April 2022. Conflicts of Interest. Nothing to disclose. 2. Objectives. Describe an approach to the work-up of chronic kidney disease (CKD). Quality Department Guidelines for Clinical Care Ambulatory Chronic Kidney Disease Guideline Team Team Leader Jennifer Reilly Lukela, MD General MedicineTeam MembersR. Van Harrison, PhDMedical Educati
Download Document
Here is the link to download the presentation.
"Module 3: Anemia in Chronic Kidney Disease"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents